AwesomeCapital
Search This Blog
Monday, March 6, 2023
Wedbush Lowers Kala Pharmaceuticals' Price Target to $42 From $47
Due to Increased Share Count, Keeps Outperform Rating
https://www.marketscreener.com/quote/stock/KALA-PHARMACEUTICALS-INC-36926679/news/Wedbush-Lowers-Kala-Pharmaceuticals-Price-Target-to-42-From-47-Due-to-Increased-Share-Count-Keep-43169564/
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.